FdaApplication
ANDA 210341
Identifiers
- fda_app_no: ANDA210341
Properties
| Property | Value |
|---|---|
| applicant_name | ALEMBIC PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2019-06-05 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CARBIDOPA AND LEVODOPA | CARBIDOPA; LEVODOPA | 25MG;100MG | TABLET, EXTENDED RELEASE;ORAL |
| CARBIDOPA AND LEVODOPA | CARBIDOPA; LEVODOPA | 50MG;200MG | TABLET, EXTENDED RELEASE;ORAL |
2 products